Leading Manufacturer for Side Effects Of Nicotinamide Mononucleotide - Epoxide hydrolase (EH) – SyncoZymes
Leading Manufacturer for Side Effects Of Nicotinamide Mononucleotide - Epoxide hydrolase (EH) – SyncoZymes Detail:
| Enzymes | Product Code | Specification |
| Enzyme Powder | ES-EH-101~ ES-EH-103 | a set of 3 Epoxide Hydrolases, 50 mg each 3 items * 50mg / item, or other quantity |
| Screening Kit (SynKit) | ES-EH-300 | a set of 3 Epoxide Hydrolases, 1 mg each 3 items * 1mg / item |
★ High substrate specificity.
★ Strong chiral selectivity.
★ High conversion.
★ Less by-products.
★ Mild reaction conditions.
★ Environmentally friendly.
➢ Normally, the reaction system should include substrate, buffer solution (optimum reaction pH) and ES-EH.
➢ All kinds of ES-EHs corresponding to various optimum reaction conditions should be studied individually.
➢ High concentration Substrate or product with may inhibit ES-EH’s activity. However, the inhibition can be relieved by batch addition of substrate.
Example 1 (1):
Keep 2 years below -20℃.
Never contact with extreme conditions such as: high temperature, high/low pH and high concentration organic solvent.
1. Kim YH, Lee I, Choi SH, e tal. J Mol Catal B-Enzym, 2013, 89: 48-51.
Product detail pictures:
Related Product Guide:
No matter new customer or old customer, We believe in long term and trusted relationship for Leading Manufacturer for Side Effects Of Nicotinamide Mononucleotide - Epoxide hydrolase (EH) – SyncoZymes , The product will supply to all over the world, such as: Lithuania, Vietnam, US, We are committed to meet all your needs and solve any technical problems you may encounter with your industrial components. Our exceptional products and vast knowledge of technology makes us the preferred choice for our customers.
By Lilith from Los Angeles - 2017.11.11 11:41
The company can think what our think, the urgency of urgency to act in the interests of our position, can be said this is a responsible company, we had a happy cooperation!
By Merry from Surabaya - 2017.09.26 12:12
